GlassScriptPhysician profile
Maureen A Maguire
NPI 1750371381
$1,193.06
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $145 · 2021: $17.41 · 2022: $163 · 2023: $115 · 2024: $38.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $206.28 | 2019-2023 | |
| Therapeuticsmd, INC. | $145.73 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $122.39 | 2019-2020 | |
| Hologic Sales and Service, LLC | $101.74 | 2019-2022 | |
| Lupin INC. | $90.54 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.86 | 2019-2020 | |
| Exeltis, USA INC. | $59.19 | 2020-2023 | Slynd |
| Millicent US INC | $55.95 | 2019-2024 | Femring, Intrarosa |
| Duchesnay USA Incorporated | $48.76 | 2019 | |
| Allergan, INC. | $47.01 | 2019-2020 | |
| Ethicon US, LLC | $37.83 | 2019 | |
| Astellas Pharma US INC | $30.13 | 2023 | Veozah, Myrbetriq |
| Merck Sharp & Dohme LLC | $29.04 | 2019 | |
| Covidien LP | $28.32 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.44 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20.26 | 2019 | |
| Eisai INC. | $19.66 | 2019 | |
| Myovant Sciences INC. | $18.51 | 2022 | |
| Mylan Pharmaceuticals INC. | $17.02 | 2019 | |
| Sumitomo Pharma America, INC. | $13.82 | 2024 | Myfembree |
| Avion Pharmaceuticals | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Maguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.